Finance

Lists
300238:SHE
Guanhao Biotech Co Ltd
CNÂ¥10,95
-1,79%
(-0,20) 1D
15 Okt., 15:04:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300238...
Open
CNÂ¥11,00
High
CNÂ¥11,19
Low
CNÂ¥10,87
Mkt. cap
3,13 mjd
Avg. vol.
4,16 m
Volume
3,62 m
P/E ratio
167,25
52-wk high
CNÂ¥18,00
52-wk low
CNÂ¥10,19
EPS
CNÂ¥0,07
Shares outstanding
274,70 m
No. of employees
535
Open
CNÂ¥11,00
High
CNÂ¥11,19
Low
CNÂ¥10,87
Mkt. cap
3,13 mjd
Avg. vol.
4,16 m
Volume
3,62 m
P/E ratio
167,25
52-wk high
CNÂ¥18,00
52-wk low
CNÂ¥10,19
EPS
CNÂ¥0,07
Shares outstanding
274,70 m
No. of employees
535
News stories
From web sources and news partners
About Guanhao Biotech Co Ltd
CEO-
Employees535
Founded22 Okt. 1999
Headquarters-
Sector-
Websitegrandhopebio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
92,61 m
94,27 m
93,44 m
81,07 m
Cost of goods sold
20,01 m
25,11 m
21,83 m
20,07 m
Cost of revenue
20,01 m
25,11 m
21,83 m
20,07 m
Research and development expenses
7,73 m
14,73 m
8,05 m
7,96 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,66 m
55,62 m
51,47 m
48,23 m
Operating expense
63,03 m
73,44 m
60,17 m
59,73 m
Total operating expenses
83,04 m
98,55 m
81,99 m
79,81 m
Operating income
9,57 m
-4,28 m
11,45 m
1,26 m
Other non operating income
-176,66 k
433,43 k
89,97 k
90,63 k
EBT including unusual items
7,33 m
-4,84 m
10,51 m
3,23 m
EBT excluding unusual items
8,59 m
-3,00 m
10,76 m
1,00 m
Income tax expense
3,42 m
802,93 k
3,31 m
2,78 m
Effective tax rate
46,60%
-16,59%
31,49%
86,04%
Other operating expenses
1,08 m
2,62 m
389,89 k
2,31 m
Net income
6,31 m
-2,37 m
10,16 m
3,08 m
Net profit margin
6,82%
-2,52%
10,88%
3,80%
Earnings per share
-
-
-
-
Interest and investment income
174,88 k
1,91 m
159,04 k
106,73 k
Interest expense
-867,53 k
-1,23 m
-942,47 k
-723,68 k
Net interest expenses
-692,65 k
674,66 k
-783,42 k
-616,95 k
Depreciation and amortization charges
-
-
-
-
EBITDA
14,65 m
856,14 k
16,59 m
6,24 m
Gain or loss from assets sale
-5,57 k
5,12 k
-
-88,78 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme